The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 1,352 | 85,558 | SH | SOLE | 85,558 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 1,454 | 8,723 | SH | SOLE | 8,723 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 534 | 5,425 | SH | SOLE | 5,425 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 1,135 | 15,970 | SH | SOLE | 15,970 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 485 | 11,123 | SH | SOLE | 11,123 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 2,507 | 71,400 | SH | SOLE | 71,400 | 0 | 0 | ||
| CIGNA CORPORATION | COM | 125509109 | 2,956 | 17,392 | SH | SOLE | 17,392 | 0 | 0 | ||
| CONCERT PHARMACEUTICALS INC | COM | 206022105 | 502 | 29,821 | SH | SOLE | 29,821 | 0 | 0 | ||
| CVS HEALTH CORP | COM | 126650100 | 1,566 | 24,330 | SH | SOLE | 24,330 | 0 | 0 | ||
| ENDOLOGIX INC | COM | 29266S106 | 517 | 91,422 | SH | SOLE | 91,422 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 338 | 67,429 | SH | SOLE | 67,429 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 1,580 | 22,300 | SH | SOLE | 22,300 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 1,001 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
| MERCK & CO INC | COM | 58933Y105 | 6,521 | 107,434 | SH | SOLE | 107,434 | 0 | 0 | ||
| MIMEDX GROUP INC | COM | 602496101 | 543 | 85,050 | SH | SOLE | 85,050 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 3,013 | 83,370 | SH | SOLE | 83,370 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 1 | 2,125 | SH | Call | SOLE | 2,125 | 0 | 0 | |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 412 | 61,304 | SH | SOLE | 61,304 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 249 | 17,090 | SH | SOLE | 17,090 | 0 | 0 | ||
| RADIUS HEALTH INC | COM NEW | 750469207 | 1,784 | 60,521 | SH | SOLE | 60,521 | 0 | 0 | ||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 1,801 | 5,220 | SH | SOLE | 5,220 | 0 | 0 | ||
| SANOFI | SPONSORED ADR | 80105N105 | 3,074 | 76,836 | SH | SOLE | 76,836 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 415 | 31,594 | SH | SOLE | 31,594 | 0 | 0 | ||
| THERAVANCE BIOPHARMA INC | COM | G8807B106 | 621 | 27,397 | SH | SOLE | 27,397 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 297 | 2,625 | SH | SOLE | 2,625 | 0 | 0 | ||